{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:07:37Z","timestamp":1776308857011,"version":"3.50.1"},"reference-count":100,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Pfizer Inc"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1111\/jcpt.13083","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T06:19:45Z","timestamp":1575958785000},"page":"270-281","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB\u2010FHbp"],"prefix":"10.1155","volume":"45","author":[{"given":"Cynthia","family":"Burman","sequence":"first","affiliation":[{"name":"Pfizer Vaccines Medical Development & Scientific and Clinical Affairs Pfizer Inc Collegeville PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Alderfer","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Medical Development & Scientific and Clinical Affairs Pfizer Inc Collegeville PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenza T.","family":"Snow","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Medical Development & Scientific and Clinical Affairs Pfizer Inc Collegeville PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"issue":"2","key":"e_1_2_7_3_1","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn AC","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_4_1","unstructured":"Centers for Disease Control and Prevention.Recommended immunization schedules for persons aged 0 through 18 years United States;2017.https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf. Accessed July 18 2017."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftx033"},{"issue":"22","key":"e_1_2_7_6_1","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged \u226510 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Folaranmi T","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_7_1","unstructured":"MacNeilJ.Considerations for use of serogroup B meningococcal (MenB) vaccines in adolescents.http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2015-06\/mening-03-macneil.pdf. Accessed April 4 2016."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6833a2"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.057"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614474"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.08.085"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013502456"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080638"},{"key":"e_1_2_7_14_1","unstructured":"Centers for Disease Control and Prevention.Letter to pharmacists;2016.http:\/\/media.pharmacist.com\/documents\/Dear_Pharmacist_letter_9-2016.pdf. Accessed May 18 2018."},{"key":"e_1_2_7_15_1","unstructured":"Centers for Disease Control and Prevention.General Best Practice Guidelines for Immunization: 11. Vaccination Programs.https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/programs.pdf. Accessed May 18 2018."},{"key":"e_1_2_7_16_1","unstructured":"Australian Government Department of Health Therapeutic Goods Administration.Prescription medicines: registration of new chemical entities in Australia.https:\/\/www.tga.gov.au\/prescription-medicines-registration-new-chemical-entities-australia. Accessed October 23 2017."},{"key":"e_1_2_7_17_1","volume-title":"Product Monograph: Trumenba Meningococcal Group B Vaccine [Bivalent Recombinant Lipoprotein (rLP2086)]","author":"Pfizer Canada Inc","year":"2017"},{"key":"e_1_2_7_18_1","unstructured":"European Medicines Agency.EPAR Summary for the Public: Trumenba.http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/004051\/WC500228998.pdf. Accessed July 12 2019."},{"key":"e_1_2_7_19_1","volume-title":"Enhanced Meningococcal Disease Surveillance Report, 2017","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)67932-4"},{"key":"e_1_2_7_21_1","unstructured":"Centers for Disease Control and Prevention.Meningococcal disease: diagnosis treatment and complications.https:\/\/www.cdc.gov\/meningococcal\/about\/diagnosis-treatment.html. Accessed November 15 2017."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"e_1_2_7_23_1","unstructured":"European Centre for Disease Prevention and Control.Surveillance atlas of infectious diseases.https:\/\/ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases. Accessed August 15 2017."},{"key":"e_1_2_7_24_1","unstructured":"Centers for Disease Control.Enhanced meningococcal disease surveillance report 2017.https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2017.pdf. Accessed May 10 2019."},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1790"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-017-0587-4"},{"key":"e_1_2_7_27_1","unstructured":"University of Massachusetts Amherst.Additional meningitis vaccine clinics set following successful large\u2010scale clinics.https:\/\/www.umass.edu\/gateway\/content\/additional-meningitis-vaccine-clinics-set-following-successful-large-scale-clinics. Accessed December 11 2017."},{"key":"e_1_2_7_28_1","unstructured":"Oregon State University Student Health Services.Health alerts.http:\/\/studenthealth.oregonstate.edu\/health-alerts. Accessed May 18 2018."},{"key":"e_1_2_7_29_1","unstructured":"University of Massachusetts Amherst.Frequently asked questions: Serogroup B meningococcal disease.http:\/\/www.umass.edu\/gateway\/sites\/default\/files\/Meningitis%20FAQs_Discharge%20Instructions.pdf. Accessed May 18 2018."},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix446"},{"key":"e_1_2_7_31_1","unstructured":"Meningitis prompts March 8 9 vaccinations.https:\/\/oregonstate.edu\/alert\/meningitis. Accessed October 2 2017."},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2503.181574"},{"key":"e_1_2_7_33_1","volume-title":"Full Prescribing Information","author":"Menactra\u00ae (meningococcal [groups A, C, Y and W\u2010135] polysaccharide diphtheria toxoid conjugate vaccine)","year":"2016"},{"key":"e_1_2_7_34_1","volume-title":"Full Prescribing Information","author":"Menveo\u00ae (meningococcal [groups A, C, Y and W\u2010135] oligosaccharide diphtheria CRM197 conjugate vaccine)","year":"2017"},{"key":"e_1_2_7_35_1","unstructured":"Centers for Disease Control and Prevention.Active Bacterial Core Surveillance (ABCs) Surveillance Reports.http:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed November 29 2017."},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5459.1816"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021911"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.4.2088-2100.2004"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.01.075"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00474-15"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix519"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00121-17"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00430-16"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.081"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.066"},{"key":"e_1_2_7_46_1","volume-title":"Full Prescribing Information","author":"Trumenba\u00ae (Meningococcal group B vaccine)","year":"2017"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.083"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34293"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00036-18"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.092"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00261-17"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1568-1573.2001"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.065"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1203238"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.01.044"},{"issue":"6","key":"e_1_2_7_59_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/INF.0000000000001124","article-title":"A phase 2, randomized, active\u2010controlled, observer\u2010blinded study to assess the immunogenicity, tolerability and safety of bivalent rLP2086, a meningococcal serogroup B vaccine, coadministered with tetanus, diphtheria and acellular pertussis vaccine and serogroup A, C, Y and W\u2010135 meningococcal conjugate vaccine in healthy US adolescents","volume":"35","author":"Muse D","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001072"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv039"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv064"},{"key":"e_1_2_7_63_1","unstructured":"Centers for Disease Control and Prevention.Recommended immunization schedules for persons aged 0 through 18 years United States 2018.https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf. Accessed May 29 2018."},{"key":"e_1_2_7_64_1","volume-title":"U. S. Advisory Committee on Immunization Practices (ACIP) Handbook for Developing Evidence\u2010based Recommendations. Version 1.2","author":"Ahmed F","year":"2013"},{"issue":"2","key":"e_1_2_7_65_1","first-page":"1","article-title":"General recommendations on immunization\u2013recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"National Center for Immunization and Respiratory Diseases","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_66_1","unstructured":"US Food and Drug Administration.Accelerated Supplement Approval April 14 2016 (Trumenba two\u2010dose schedule).http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM496391.pdf. Accessed October 23 2017."},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000866"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.02.025"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.10.907"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2193"},{"issue":"3","key":"e_1_2_7_72_1","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines \u2013\u2010 Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.11.073"},{"key":"e_1_2_7_74_1","unstructured":"Centers for Disease Control and Prevention.Meningococcal outbreaks.https:\/\/www.cdc.gov\/meningococcal\/outbreaks\/index.html. Accessed October 18 2017."},{"key":"e_1_2_7_75_1","unstructured":"Oregon State University.Meningitis prompts March 8 9 vaccinations.https:\/\/oregonstate.edu\/alert\/meningitis. Accessed October 2 2017."},{"issue":"18","key":"e_1_2_7_76_1","first-page":"327","article-title":"New framework (GRADE) for development of evidence\u2010based recommendations by the Advisory Committee on Immunization Practices","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_77_1","volume-title":"ACIP Meeting \u2010 Updated ACIP statement for meningococcal vaccination in the United States","author":"Mbaeyi SA"},{"key":"e_1_2_7_78_1","unstructured":"RomeroJ CohnA.Welcome and Introductions. Advisory Committee on Immunization Practices (ACIP).https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2019-06\/Welcome-Romero-Cohn-508.pdf. Accessed September 10 2019."},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3484"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2018.04.005"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0344"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1890"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-4186"},{"key":"e_1_2_7_84_1","unstructured":"PenhR.Meningitis vaccination clinics take over Viejas Arena after campus outbreak.https:\/\/thedailyaztec.com\/91141\/news\/meningitis-vaccination-clinics-take-over-viejas-arena-after-campus-outbreak\/. Accessed November 15 2018."},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2018.01.002"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.161.3.252"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1177\/1942602X17709319"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.07.001"},{"key":"e_1_2_7_89_1","unstructured":"Immunization Action Coalition.Meningococcal B Vaccine: CDC Answers Your Questions.http:\/\/www.immunize.org\/catg.d\/p2040.pdf. Accessed September 29 2017."},{"key":"e_1_2_7_90_1","unstructured":"Centers for Disease Control and Prevention.Enhanced meningococcal disease surveillance report 2016.https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report.pdf. Accessed April 2 2018."},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2130"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2018.03.018"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1547606"},{"issue":"7","key":"e_1_2_7_94_1","first-page":"1","article-title":"National Center for Infectious Diseases\/Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha OO","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_95_1","unstructured":"Rutgers University Student Health.Health advisory \u2010 Serogroup B meningococcal disease (\"Meningitis B\").health.rutgers.edu\/meningitis\/#current-status. Accessed May 9 2019."},{"key":"e_1_2_7_96_1","unstructured":"Columbia Health.Health advisory: Meningococcal disease.https:\/\/health.columbia.edu\/news\/health-advisory-meningococcal-disease. Accessed May 9 2019."},{"key":"e_1_2_7_97_1","unstructured":"AllenM.Meningitis update letter from the Dean of Students.https:\/\/studenthealth.blogs.bucknell.edu\/2017\/11\/26\/meningitis-update-letter-from-the-dean-of-students\/. Accessed May 9 2019."},{"key":"e_1_2_7_98_1","unstructured":"LombardoP FerrisME FinegoldK CaesarJ.2013 Meningococcal Serogroup B Outbreak UC Santa Barbara. Presented at: Risk Summit; June 16\u201318 2014;Ontario CA."},{"key":"e_1_2_7_99_1","unstructured":"LehighValleyLive.UPDATE: University confirms two meningitis cases takes preventive measures.https:\/\/www.lehighvalleylive.com\/thebrownandwhiteblog\/2011\/11\/update_university_confirms_two.html. Accessed May 9 2019."},{"key":"e_1_2_7_100_1","unstructured":"SDSU News Center.Additional meningococcal meningitis case confirmed; vaccinations recommended.newscenter.sdsu.edu\/sdsu_newscenter\/news_story.aspx?sxml:id=77389. Accessed May 9 2019."},{"key":"e_1_2_7_101_1","volume-title":"Summary of Product Characteristics","author":"Bexsero (4CMenB)","year":"2018"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.13083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.13083","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:42Z","timestamp":1671818682000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.13083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1111\/jcpt.13083"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.13083","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"2019-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}